Show simple item record

dc.contributor.authorStone, Jeremy G.
dc.contributor.authorSiedlak, Sandra L.
dc.contributor.authorTabaton, Massimo
dc.contributor.authorHirano, Asao
dc.contributor.authorCastellani, Rudy J.
dc.contributor.authorSantocanale, Corrado
dc.contributor.authorPerry, George
dc.contributor.authorSmith, Mark A.
dc.contributor.authorZhu, Xiongwei
dc.contributor.authorLee, Hyoung-gon
dc.identifier.citationStone, Jeremy G. Siedlak, Sandra L.; Tabaton, Massimo; Hirano, Asao; Castellani, Rudy J.; Santocanale, Corrado; Perry, George; Smith, Mark A.; Zhu, Xiongwei; Lee, Hyoung-gon (2011). The cell cycle regulator phosphorylated retinoblastoma protein is associated with tau pathology in several tauopathies. Journal of Neuropathology & Experimental Neurology 70 (7), 578-587
dc.description.abstractRetinoblastoma protein (pRb) is a ubiquitous 928-amino acid cell cycle regulatory molecule with diverse biologic activities. One critical function of pRb is the control of the G(1)-to-S phase checkpoint of the cell cycle. In the hypophosphorylated state, pRb suppresses the activity of E2F transcription factors thereby inhibiting transcription of cell cycle-promoting genes. On phosphorylation, primarily by cyclin-dependent kinases, phosphorylated pRb dissociates from E2F and permits cell cycle progression. We previously found phosphorylated pRb to be intimately associated with hyperphosphorylated tau-containing neurofibrillary tangles of Alzheimer disease (AD), the pathogenesis of which is believed to involve dysregulation of the cell cycle and marked neuronal death. Here, we used immunohistochemistry to investigate the presence of phosphorylated pRb in other distinct neurodegenerative diseases that share the common characteristic of hyperphosphorylated tau pathology and neuronal loss with AD. We found colocalized labeling of tau pathology and phosphorylated pRb in Pick disease and progressive supranuclear palsy (3 cases each), neurodegeneration with brain iron accumulation type 1 (2 cases), and Parkinson-amyotrophic lateral sclerosis of Guam, subacute sclerosing panencephalitis, frontotemporal dementia and Parkinsonism linked to chromosome 17, and dementia pugilistica (1 case each). These observations further implicate aberrant neuronal cell cycle progression in neurodegenerative diseases, particularly tauopathies, and suggest a novel target for therapeutic intervention.
dc.publisherOxford University Press (OUP)
dc.relation.ispartofJournal of Neuropathology & Experimental Neurology
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 Ireland
dc.subjectdementia pugilistica
dc.subjectneurodegeneration with brain iron accumulation type 1
dc.subjectneurofibrillary tangles
dc.subjectpick disease
dc.subjectprogressive supranuclear palsy
dc.subjectretinoblastoma protein
dc.subjectsubacute sclerosing panencephalitis
dc.subjecttau pathology
dc.subjectprogressive supranuclear palsy
dc.subjectmicrotubule-associated protein
dc.subjectprb phosphorylation
dc.subject2-hit hypothesis
dc.subjectoxidative stress
dc.titleThe cell cycle regulator phosphorylated retinoblastoma protein is associated with tau pathology in several tauopathies

Files in this item


This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivs 3.0 Ireland
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 Ireland